[3]
Singhal, S.; Arora, S.; Agarwal, S.; Sharma, R.; Singhal, N. A review on potential biological activities of thiosemicarbazides. World J. Pharm. Pharm. Sci., 2013, 2, 4661-4681.
[4]
Siddiqui, E.J.; Azad, I.; Khan, A.R.; Khan, T. Thiosemicarbazone complexes as versatile medicinal chemistry agents: A review. J. Drug Deliv. Ther., 2019, 9(3), 689-703.
[14]
Tonew, M.; Tonew, E.; Heinisch, L. Antiviral thiosemicarbazones and related compounds. 2. Antiviral action of substituted isatinisothiosemicarbazones. Acta Virol., 1974, 18(1), 17-24.
[16]
Smejkal, F.; Budesinsky, Z.; Sulka, J.; Kuchar, M. Study of antiviral activity of some amantadine, pyrimidine, and isatine analogs. Adv. Antimicrob. Antineoplast. Chemother., 1972, 1(2), 879-883.
[27]
Bolsunova, O.I.; Zaika, L.A.; Potopalsky, A. I.; Voznyuk, A.V. Izatizon, as an izatin-thiosemicarbazone derivative, has antiviral, anti-tumor actions and no side effects. Int. J. Pharm. Sci. Inv, 2017, 6(5), 7-9.
[29]
Kovala-Demertzi, D.; Varadinova, T.; Genova, P.; Souza, P.; Demertzis, M.A. Platinum (II) and palladium (II) complexes of pyridine-2-carbaldehyde thiosemicarbazone as alternative antiherpes simplex virus agents. Bioinorg. Chem. Appl., 2007, 2007, 56165.
[44]
Altamura, S.; Koch, U. Treating hepatitis C viral infections with thiosemicarbazone compounds. U.S. patent application US 10/125,940, 2003 Mar 6;
[53]
De Clercq, E. The nucleoside reverse transcriptase inhibitors, nonnucleoside reverse transcriptase inhibitors, and protease inhibitors in the treatment of HIV infections (AIDS). Adv. Pharmacol. Academic Press, 2013, 67, 317-358.
[79]
Mishra, P.; Subudhi, B.B. Molecular docking studies of MBZM-N-IBT on non-structural protein targets of Dengue virus. Der Pharma Chem., 2016, 8(16), 149-153.
[80]
Fields, N.B.; David, M.K.; Robert, M.C.; Joseph, L.M.; Bernard, R.; Robert, E.S. Fields Virology; Raven Press: New York, 1985, pp. 739-794.
[93]
Swain, R.P.; Subudhi, B.B. Amorphous solid dispersions of pioglitazone hydrochloride using cremophor rh 40 and poloxamer 188: In vitro and in vivo evaluation. Indian Drugs, 2019, 56(1), 45-55.
[94]
Mohapatra, T.K.; Sarkar, P.; Dash, R.N.; Moharana, A.K.; Subudhi, B.B. Evaluation of complementary effects of turmeric, ginger and cinnamon with aspirin. Indian Drugs, 2018, 55(7), 28-35.